The Story of Next-Generation Sequencing: From Idea to Impact
Aug 24, 2025
If you’ve ever taken a biology class, you’ve probably heard about DNA being the “blueprint of life.” But have you ever wondered: how do scientists actually read that blueprint?
The answer has changed dramatically over the past 50 years, and the technology that now drives modern biology and medicine is called next-generation sequencing (NGS).
The Early Days: Reading DNA One Letter at a Time
In the 1970s, scientists figured out the first real methods to read DNA. Two main approaches came forward:
- Maxam-Gilbert sequencing (1977) – a chemical method that involved breaking DNA at specific bases. It worked, but it was messy and hard to scale.
- Sanger sequencing (1977) – a cleaner approach that used chain-terminating molecules to reveal the sequence. This became the gold standard for decades.
Sanger sequencing was powerful but slow. Imagine trying to read an entire book by hand, one letter at a time—that’s what sequencing a genome felt like.
The Human Genome Project: A Giant Leap
By the 1990s, scientists wanted to read the entire human genome—3 billion base pairs. Using Sanger sequencing, the Human Genome Project launched in 1990. It took 13 years and nearly $3 billion to complete.
This was a landmark achievement. But it also highlighted the problem: if it takes that much time and money to sequence one genome, how could we ever use this in medicine?
Enter Next-Generation Sequencing
In the mid-2000s, a revolution began. New technologies allowed DNA to be read in parallel, meaning millions of fragments could be sequenced at once instead of one by one. This is what we now call next-generation sequencing (NGS).
- 2005: 454 Pyrosequencing became the first commercial “NGS” platform.
- 2006–2007: Illumina introduced sequencing-by-synthesis, which quickly became the dominant method.
- 2010s: Other platforms like SOLiD and Ion Torrent appeared, each offering new twists.
- Now: Newer approaches (sometimes called “third-generation sequencing”) like PacBio and Oxford Nanopore can even read very long stretches of DNA in real time.
The difference was night and day. What once cost billions of dollars now costs less than $1,000 per human genome—and the speed keeps improving.
Why This Matters for Medicine
NGS didn’t just make sequencing faster and cheaper—it changed the questions we could ask.
- Cancer Genomics
Doctors can now sequence tumors to see which mutations drive growth, helping guide personalized treatments. - Rare Diseases
Whole-exome and whole-genome sequencing allow families to find the genetic causes of conditions that used to remain mysterious. - Infectious Diseases
During the COVID-19 pandemic, NGS allowed scientists to track the virus as it mutated around the world—something impossible a generation ago. - Pharmacogenomics
By sequencing patients’ genes, we can predict how they’ll respond to certain drugs. This moves us closer to truly personalized medicine.
The Future of Sequencing
The field is still evolving. Costs continue to drop, accuracy improves, and real-time sequencing is opening doors for bedside applications. Imagine a future where a patient’s genome is sequenced as easily as getting a blood test, guiding care in real time.
Why Students Should Care
As a student interested in science or medicine, understanding NGS is like understanding how the microscope changed biology centuries ago. It’s not just a tool—it’s a lens that reshaped how we see life itself.
Whether you go into medicine, research, or biotechnology, NGS will continue to shape the world you’re stepping into.
👉 If you’d like to dive deeper, I recommend checking out simple resources like Illumina’s introduction to sequencing or tutorials on Genomics Education Programme. If this story fascinates you, I highly recommend reading The Gene by Siddhartha Mukherjee. It’s a beautifully written history of genetics that captures both the science and the human stories behind it.